Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R2QS
|
||||
| Former ID |
DNC001008
|
||||
| Drug Name |
Neplanocin A
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Terminated | [544782] | ||
| Formula |
C11H13N5O3
|
||||
| Canonical SMILES |
C1=C(C(C(C1N2C=NC3=C2N=CN=C3N)O)O)CO
|
||||
| InChI |
1S/C11H13N5O3/c12-10-7-11(14-3-13-10)16(4-15-7)6-1-5(2-17)8(18)9(6)19/h1,3-4,6,8-9,17-19H,2H2,(H2,12,13,14)/t6-,8-,9+/m1/s1
|
||||
| InChIKey |
XUGWUUDOWNZAGW-VDAHYXPESA-N
|
||||
| CAS Number |
CAS 72877-50-0
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosylhomocysteinase | Target Info | Inhibitor | [537918] | |
| KEGG Pathway | Cysteine and methionine metabolism | ||||
| Metabolic pathways | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.